Epigenetic changes in cancer.

Cancer is as much an epigenetic disease as it is a genetic disease, and epigenetic alterations in cancer often serve as potent surrogates for genetic mutations. Normal epigenetic modifications of DNA encompass three types of changes: chromatin modifications, DNA methylation, and genomic imprinting, each of which is altered in cancer cells. This review addresses the various epigenetic modifications that are pervasive among human tumors and traces the history of cancer epigenetics from the first observations of altered global methylation content to the recently proposed epigenetic progenitor model, which provides a common unifying mechanism for cancer development.

[1]  S. Kim,et al.  Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer. , 2008, Oncology reports.

[2]  H. Müller-Hermelink,et al.  Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling. , 2008, The American journal of pathology.

[3]  I. Okayasu,et al.  Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma , 2008, Laboratory Investigation.

[4]  A. Feinberg,et al.  Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk , 2007, Proceedings of the National Academy of Sciences.

[5]  J. Serth,et al.  Adiposity and Age are Statistically Related to Enhanced RASSF1A Tumor Suppressor Gene Promoter Methylation in Normal Autopsy Kidney Tissue , 2007, Cancer Epidemiology Biomarkers & Prevention.

[6]  Paul Tempst,et al.  Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. , 2007, Molecular cell.

[7]  Yang Shi,et al.  Histone lysine demethylases: emerging roles in development, physiology and disease , 2007, Nature Reviews Genetics.

[8]  Scott A. Armstrong,et al.  MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.

[9]  T. Rasmussen,et al.  Global Epiproteomic Signatures Distinguish Embryonic Stem Cells from Differentiated Cells , 2007, Stem cells.

[10]  P. Marks,et al.  Histone Deacetylase Inhibitors: Overview and Perspectives , 2007, Molecular Cancer Research.

[11]  H. Donninger,et al.  The RASSF1A tumor suppressor , 2007, Journal of Cell Science.

[12]  C. Allis,et al.  Chromatin remodeling and cancer, Part I: Covalent histone modifications. , 2007, Trends in molecular medicine.

[13]  D. Peters,et al.  Rubinstein–Taybi syndrome: clinical and molecular overview , 2007, Expert Reviews in Molecular Medicine.

[14]  Danny Reinberg,et al.  Methylation-Acetylation Interplay Activates p53 in Response to DNA Damage , 2007, Molecular and Cellular Biology.

[15]  L. Looijenga,et al.  Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors. , 2007, Oncology reports.

[16]  Manel Esteller,et al.  Mutator pathways unleashed by epigenetic silencing in human cancer. , 2007, Mutagenesis.

[17]  M. Esteller.  Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.

[18]  Yi Zhang,et al.  Regulation of histone methylation by demethylimination and demethylation , 2007, Nature Reviews Molecular Cell Biology.

[19]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[20]  J. Minna,et al.  DNA methylation in health, disease, and cancer. , 2007, Current molecular medicine.

[21]  Xinmin Zhou,et al.  Promoter Hypermethylation of the RUNX3 Gene in Esophageal Squamous Cell Carcinoma , 2007, Cancer investigation.

[22]  Y. Kotake,et al.  pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. , 2007, Genes & development.

[23]  E. Ostertag,et al.  Current topics in genome evolution: Molecular mechanisms of new gene formation , 2007, Cellular and Molecular Life Sciences.

[24]  Kelly M. McGarvey,et al.  The cancer epigenome--components and functional correlates. , 2006, Genes & development.

[25]  Gyeong Hoon Kang,et al.  DNA Hypomethylation of CAGE Promotors in Squamous Cell Carcinoma of Uterine Cervix , 2006, Annals of the New York Academy of Sciences.

[26]  A. Rickinson,et al.  Methylation Status of theEpstein-Barr Virus (EBV) BamHI W Latent Cycle Promoter and Promoter Activity: Analysis with Novel EBV-Positive Burkitt and LymphoblastoidCell Lines , 2006, Journal of Virology.

[27]  M. Szyf,et al.  Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation. , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[28]  T. Jenuwein.  The epigenetic magic of histone lysine methylation , 2006, The FEBS journal.

[29]  L. Aaltonen,et al.  A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition , 2006, Nature Genetics.

[30]  Christian B. Woods,et al.  Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors , 2006, Oncogene.

[31]  Florentia M. Smith,et al.  Regulation of growth and metabolism by imprinted genes , 2006, Cytogenetic and Genome Research.

[32]  W. Reik,et al.  How imprinting centres work , 2006, Cytogenetic and Genome Research.

[33]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[34]  A. Bird,et al.  Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.

[35]  G. Watanabe,et al.  DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer , 2006, British Journal of Cancer.

[36]  K. Schuebel,et al.  Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation. , 2006, Cancer research.

[37]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[38]  Tony Kouzarides,et al.  Reversing histone methylation , 2005, Nature.

[39]  Antonio Porro,et al.  In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Goggins,et al.  Epigenetic Down-Regulation of CDKN1C/p57KIP2 in Pancreatic Ductal Neoplasms Identified by Gene Expression Profiling , 2005, Clinical Cancer Research.

[41]  Thomas A. Milne,et al.  WDR5 Associates with Histone H3 Methylated at K4 and Is Essential for H3 K4 Methylation and Vertebrate Development , 2005, Cell.

[42]  T. Zerjal,et al.  CENP-A Is Required for Accurate Chromosome Segregation and Sustained Kinetochore Association of BubR1 , 2005, Molecular and Cellular Biology.

[43]  S. Hirohashi,et al.  DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. , 2005, The Journal of urology.

[44]  R. Gibbons.  Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. , 2005, Human molecular genetics.

[45]  D. Reinberg,et al.  The key to development: interpreting the histone code? , 2005, Current opinion in genetics & development.

[46]  G. Pfeifer,et al.  The tumor suppressor RASSF1A in human carcinogenesis: an update. , 2005, Histology and histopathology.

[47]  A. Feinberg,et al.  Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice , 2005, Science.

[48]  M. Fraga,et al.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.

[49]  D. Hansemann.  Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung , 1890, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[50]  S. Hirohashi,et al.  DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas. , 2005, The Journal of urology.

[51]  Shingo Matsumoto,et al.  Loss of imprinting of PEG1/MEST in lung cancer cell lines. , 2004, Oncology reports.

[52]  J. Mata,et al.  Methylation of Histone H4 Lysine 20 Controls Recruitment of Crb2 to Sites of DNA Damage , 2004, Cell.

[53]  Tom J. Petty,et al.  Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks , 2004, Nature.

[54]  G. Martin,et al.  The road to Src , 2004, Oncogene.

[55]  Kristian Helin,et al.  Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity , 2004, The EMBO journal.

[56]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[57]  K. Schuebel,et al.  CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1 , 2004, Nature Genetics.

[58]  Yi Zhang,et al.  The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. , 2004, Current opinion in genetics & development.

[59]  A. Feinberg,et al.  Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. , 2004, Gastroenterology.

[60]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[61]  A. Schatzkin,et al.  Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. , 2004, Journal of the National Cancer Institute.

[62]  W. Gu,et al.  Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[64]  Xiang-Jiao Yang.  The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. , 2004, Nucleic acids research.

[65]  S. Markowitz,et al.  Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability , 2004, Oncogene.

[66]  B. Horsthemke,et al.  Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma , 1989, Human Genetics.

[67]  J. Hess.  Mechanisms of transformation by MLL. , 2004, Critical reviews in eukaryotic gene expression.

[68]  T. Jenuwein,et al.  Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases , 2004, Nature Genetics.

[69]  J. Herman,et al.  GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer , 2003, Molecular and Cellular Biology.

[70]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[71]  Shi Huang,et al.  Inactivation of a histone methyltransferase by mutations in human cancers. , 2003, Cancer research.

[72]  Kristian Helin,et al.  EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.

[73]  S. Nomoto,et al.  Biallelic inactivation of the RIZ1 gene in human gastric cancer , 2003, Oncogene.

[74]  Donald E. Olins,et al.  Chromatin history: our view from the bridge , 2003, Nature Reviews Molecular Cell Biology.

[75]  Debashis Ghosh,et al.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Hansoo Lee,et al.  Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. , 2003, Biochemical and biophysical research communications.

[77]  T. Tomonaga,et al.  Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. , 2003, Cancer research.

[78]  C. Wheeler,et al.  CpG Methylation of Human Papillomavirus Type 16 DNA in Cervical Cancer Cell Lines and in Clinical Specimens: Genomic Hypomethylation Correlates with Carcinogenic Progression , 2003, Journal of Virology.

[79]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[80]  R. Jaenisch,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.

[81]  K. Luger.  Structure and dynamic behavior of nucleosomes. , 2003, Current opinion in genetics & development.

[82]  R. Hruban,et al.  Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[83]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in X Inactivation , 2003, Science.

[84]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[85]  F. Bazzoli,et al.  Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. , 2003, Cancer research.

[86]  P. Farnham,et al.  Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. , 2003, Molecular cancer therapeutics.

[87]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[88]  Rachel Jones,et al.  Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.

[89]  A. Feinberg,et al.  Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. , 2002, Cancer research.

[90]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[91]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[92]  J. J. Breen,et al.  BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[93]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[94]  I. Fidler,et al.  Critical determinants of metastasis. , 2002, Seminars in cancer biology.

[95]  A. Feinberg,et al.  Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. , 2001, Journal of the National Cancer Institute.

[96]  Karl Mechtler,et al.  Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability , 2001, Cell.

[97]  Richard A. Rifkind,et al.  Cloning and characterization of a histone deacetylase, HDAC9 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[98]  R. Chadwick,et al.  Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. , 2001, Genes & development.

[99]  J. Cheng,et al.  A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. , 2001, Blood.

[100]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[101]  A. Feinberg,et al.  Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. , 2001, Cancer research.

[102]  K. Struhl,et al.  Histone Acetylation at Promoters Is Differentially Affected by Specific Activators and Repressors , 2001, Molecular and Cellular Biology.

[103]  A. Verdel,et al.  Functional significance of histone deacetylase diversity. , 2001, Current opinion in genetics & development.

[104]  R. Willemze,et al.  The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma , 2001, British journal of haematology.

[105]  C. Plass,et al.  Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[106]  T. Ekström,et al.  The human histone deacetylase family. , 2001, Experimental cell research.

[107]  I. Adcock,et al.  Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.

[108]  Peter L. Jones,et al.  DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters , 2000, Nature Genetics.

[109]  M. Ehrlich,et al.  DNA hypomethylation and unusual chromosome instability in cell lines fromICF syndrome patients , 2000, Cytogenetic and Genome Research.

[110]  R. Sternglanz,et al.  The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[111]  S. Chi,et al.  Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[112]  J. Herman,et al.  CpG methylation is maintained in human cancer cells lacking DNMT1 , 2000, Nature.

[113]  R. Chadwick,et al.  Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[114]  T. Kouzarides,et al.  Regulation of E2F1 activity by acetylation , 2000, The EMBO journal.

[115]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[116]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[117]  E. Ballestar,et al.  Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation , 1999, Nature Genetics.

[118]  Paul Tempst,et al.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex , 1999, Nature Genetics.

[119]  R. Frye,et al.  Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. , 1999, Biochemical and biophysical research communications.

[120]  M. Ehrlich,et al.  Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. , 1999, Cancer genetics and cytogenetics.

[121]  M. Ehrlich,et al.  Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. , 1999, Mutation research.

[122]  C. Walsh,et al.  Cytosine methylation and mammalian development. , 1999, Genes & development.

[123]  V. Ogryzko,et al.  Regulation of activity of the transcription factor GATA-1 by acetylation , 1998, Nature.

[124]  M. Bartolomei,et al.  Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. , 1998, Genes & development.

[125]  S. Baylin,et al.  Hypomethylation of pericentromeric DNA in breast adenocarcinomas , 1998, International journal of cancer.

[126]  Rudolf Jaenisch,et al.  DNA hypomethylation leads to elevated mutation rates , 1998, Nature.

[127]  T. Hoshino,et al.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[128]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[129]  S. Minucci,et al.  Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.

[130]  T. Dryja,et al.  Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. , 1997, Cancer genetics and cytogenetics.

[131]  K. Kinzler,et al.  DNA methylation and genetic instability in colorectal cancer cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[132]  T. Iwama,et al.  p300 gene alterations in colorectal and gastric carcinomas. , 1996, Oncogene.

[133]  G. Shao,et al.  The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[134]  A. Feinberg,et al.  Parental Imprinting of Human Chromosome Region 11p15.3-pter Involved in the Beckwith-Wiedemann Syndrome and Various Human Neoplasia , 1994, European journal of human genetics : EJHG.

[135]  S. Baylin,et al.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.

[136]  John Calvin Reed,et al.  bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia , 1993 .

[137]  T. Sakai,et al.  CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. , 1993, Oncogene.

[138]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[139]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[140]  C. Sapienza,et al.  A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting , 1989 .

[141]  D. Haig,et al.  Parent-Specific Gene Expression and the Triploid Endosperm , 1989, The American Naturalist.

[142]  S. Baylin,et al.  Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. , 1987, Blood.

[143]  W. Lee,et al.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.

[144]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[145]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[146]  K. Ohama,et al.  Androgenetic origin of hydatidiform mole , 1977, Nature.

[147]  D. Linder.  Gene loss in human teratomas. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[148]  A. Mirsky,et al.  ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS. , 1964, Proceedings of the National Academy of Sciences of the United States of America.

[149]  Garrison Fh,et al.  [History of cancer]. , 1926, Il Policlinico. Sezione pratica.